Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Danna Dennis-Calder

Physician Assistant, Medical Atlanta, GA Physician Assistant

NPI 1811080914 CMS profile 11238500

5555 Peachtree Dunwoody Rd Ste 190, Atlanta, GA 30342

Open in the dashboard

General payments

$86,826

679 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Danna Dennis-Calder of Atlanta, GA is reported in the CMS Open Payments database as having received $86,826 across 679 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20,356 119
2024 General $27,810 190
2023 General $10,977 144
2022 General $14,664 146
2021 General $13,019 80

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Danna Dennis-Calder
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Danna Dennis-Calder were reported at $20,356. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Danna Dennis-Calder Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $13,019 $156 $41–$563 $132
2022 $14,664 $185 $55–$649 $149
2023 $10,977 $199 $58–$717 $160
2024 $27,810 $206 $62–$740 $164
2025 $20,356 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $82,329 379 payments
  2. Novartis Pharmaceuticals Corporation $986 74 payments
  3. Janssen Biotech, Inc. $453 22 payments
  4. Dermavant Sciences, Inc. $315 15 payments
  5. E.R. Squibb & Sons, L.L.C. $300 22 payments
  6. Incyte Corporation $264 13 payments
  7. Regeneron Healthcare Solutions, Inc. $243 13 payments
  8. Sun Pharmaceutical Industries Inc. $210 8 payments
  9. Mayne Pharma Inc. $183 33 payments
  10. Lilly USA, LLC $179 10 payments
  11. Other $1,364 90 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $71,275 53 payments
  2. Food and Beverage $10,502 585 payments
  3. Consulting Fee $3,575 4 payments
  4. Travel and Lodging $1,296 34 payments
  5. Education $178 3 payments
Products named General payments · program years 2021–2025
  1. SKYRIZI Immunology $52,661 197 payments
  2. SKYRIZI Immunology $16,198 41 payments
  3. RINVOQ $6,439 112 payments
  4. HUMIRA $4,443 42 payments
  5. COSENTYX Dermatology $525 41 payments
  6. COSENTYX Immunology $418 31 payments
  7. TREMFYA $396 19 payments
  8. VTAMA $343 18 payments
  9. SOTYKTU $300 22 payments
  10. OPZELURA $264 13 payments
  11. Other $2,661 161 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

212

Median for Physician Assistant: 241

Drug cost

$4,923

Median for Physician Assistant: $4,110

Branded share of claims

5.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dutasteride Generic 100 $2,818
Clobetasol Propionate Generic 23 $1,120
Ketoconazole Generic 39 $335
Valacyclovir Valacyclovir Hcl Brand 11 $248
Triamcinolone Acetonide Generic 21 $238
Mupirocin Generic 18 $164

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 27 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SKYRIZI
  • AbbVie, Inc. $26,007
$26,007 — —
RINVOQ
  • AbbVie, Inc. $387
$387 — —
VTAMA
  • Dermavant Sciences, Inc. $271
$271 — —
COSENTYX
  • Novartis Pharmaceuticals Corporation $146
$146 — —
ADBRY
  • LEO Pharma Inc. $141
$141 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 27 with Patron

Records

679 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record